case_images: PMC8095300_01
case_images: (a) Clinical picture at presentation (b) corresponding optical coherence tomography
case_images: OJO-14-49-g001.jpg
case_images: PMC8095300_01_OJO-14-49-g001.jpg
case_images: F1
case_images: A provisional diagnosis of RE hemicentral retinal vein occlusion (CRVO) with CME was made [Figure 1a]. Optical coherence tomography (OCT) showed a central macular thickness of 551 mu with intraretinal cystic spaces and fluid [Figure 1b].
case_images: (a) Full-thickness macular hole following injection (b) full-thickness macular hole-corresponding optical coherence tomography
case_images: OJO-14-49-g002.jpg
case_images: PMC8095300_01_OJO-14-49-g002.jpg
case_images: F2
case_images: OCT of RE revealed a full thickness MH a month later! [Figure 2a and b] She was explained about requiring surgery. Over the next 18 months, she received 5 more injections of intravitreal Bevacizumab.
case_images: (a) Following vitrectomy (b) Optical coherence tomography following vitrectomy- Type 1 closure
case_images: OJO-14-49-g003.jpg
case_images: PMC8095300_01_OJO-14-49-g003.jpg
case_images: F3
case_images: Four months postsurgery, her RE BCVA 6/24 with cataract formation and MH Type 1 (U-shaped) closure was seen [Figure 3a and b].
case_images: Clinical picture - last visit
case_images: OJO-14-49-g004.jpg
case_images: PMC8095300_01_OJO-14-49-g004.jpg
case_images: F4
case_images: She has remained in regular follow-ups ever since and her BCVA has remained stable at 6/9 [Figure 4].